Literature DB >> 24100801

Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube.

Johannes Dietl1.   

Abstract

BACKGROUND: Among all gynecological malignancies, ovarian cancer is associated with the highest rate of mortality. Recent findings now propose a pivotal role for the fallopian tube during ovarian cancer pathogenesis. NEW INSIGHTS: Until recently, ovarian cancer was thought to derive from the ovarian surface epithelium. Nevertheless, attempts to define a precursor lesion from this tissue failed. Instead, prophylactic surgery performed on BRCA mutation carriers and subsequent histological analyses revealed a characteristic pre-neoplastic alteration at the fimbriated end of the fallopian tubes, the so-called serous tubal intraepithelial carcinoma (STIC). By morphology and molecular genetics, STIC was found to resemble serous ovarian cancer. As STIC can also be detected in >60 % of BRCA-unrelated serous ovarian carcinomas, it is now considered to be the precursor of the most common ovarian cancer subtype. CONSEQUENCES: Based on this hypothesis, a salpingectomy, i.e., the removal of the post-reproductive fallopian tubes may remove the actual site of tumorigenesis and thereby prevent spreading over the ovarian surface and throughout the peritoneum. Consequently, prophylactic salpingectomy might protect against serous ovarian cancer. Moreover, the procedure interrupts the connection between the uterine cavity and the lesser pelvis. Hence, it prevents the ascension of exfoliated endometrial cells which will likely reduce the incidence of endometrioid and clear cell ovarian cancers. Increasing evidence suggests that serous ovarian cancer originates from the fimbriated distal end of the fallopian tube, whereas the ovary gets only involved at a later stage.
CONCLUSION: Given the lack of suitable screening or early detection strategies for ovarian cancer, post-reproductive salpingectomy deserves serious consideration as a prophylactic intervention that will likely confer significant protection against an often deadly disease.

Entities:  

Mesh:

Year:  2013        PMID: 24100801     DOI: 10.1007/s00404-013-3041-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  12 in total

1.  Olive oil exhibits osteoprotection in ovariectomized rats without estrogenic effects.

Authors:  Xiaohua Zheng; Huijuan Huang; Xiaobing Zheng; Baoheng Li
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

2.  Reversal of tubo-ovarian atypical epithelial patterns after cessation of ovarian stimulation by letrozole.

Authors:  Ahmed A M Abdel-Hamid; Yaser Mesbah; Mona F M Soliman
Journal:  Int J Exp Pathol       Date:  2016-09-01       Impact factor: 1.925

3.  Palmar fasciitis with polyarthritis-associated ovarian cancer: Case report and literature review.

Authors:  Hiroyuki Kajikawa; Takuya Sobajima; Chinatsu Koiwai; Satoshi Ichigo; Hiroshi Takagi; Atsushi Imai
Journal:  Mol Clin Oncol       Date:  2017-11-24

4.  Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years.

Authors:  Zhezhou Huang; Ying Zheng; Wanqing Wen; Chunxiao Wu; Pingping Bao; Chunfang Wang; Weijian Zhong; Yu-Tang Gao; Fan Jin; Yong-Bing Xiang; Xiao-Ou Shu; Alicia Beeghly-Fadiel
Journal:  Eur J Cancer       Date:  2016-05-26       Impact factor: 9.162

5.  Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.

Authors:  Marline G Harmsen; Marieke Arts-de Jong; Nicoline Hoogerbrugge; Angela H E M Maas; Judith B Prins; Johan Bulten; Steven Teerenstra; Eddy M M Adang; Jurgen M J Piek; Helena C van Doorn; Marc van Beurden; Marian J E Mourits; Ronald P Zweemer; Katja N Gaarenstroom; Brigitte F M Slangen; M Caroline Vos; Luc R C W van Lonkhuijzen; Leon F A G Massuger; Rosella P M G Hermens; Joanne A de Hullu
Journal:  BMC Cancer       Date:  2015-08-19       Impact factor: 4.430

6.  Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer.

Authors:  Jonna Berntsson; Sebastian Lundgren; Björn Nodin; Mathias Uhlén; Alexander Gaber; Karin Jirström
Journal:  J Ovarian Res       Date:  2014-02-26       Impact factor: 4.234

7.  Iron addiction: a novel therapeutic target in ovarian cancer.

Authors:  D Basuli; L Tesfay; Z Deng; B Paul; Y Yamamoto; G Ning; W Xian; F McKeon; M Lynch; C P Crum; P Hegde; M Brewer; X Wang; L D Miller; N Dyment; F M Torti; S V Torti
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

8.  Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer.

Authors:  Ghazala Khan; Suzanne E Brooks; Ken I Mills; Barbara-Ann Guinn
Journal:  Biomark Cancer       Date:  2015-08-16

9.  Primary fallopian tube carcinoma: review of MR imaging findings.

Authors:  Filipe Veloso Gomes; João Lopes Dias; Rita Lucas; Teresa Margarida Cunha
Journal:  Insights Imaging       Date:  2015-07-07

10.  Magnetic resonance diffusion-weighted imaging in diagnostics of primary fallopian tube carcinoma - is it useful?

Authors:  Laretta Grabowska-Derlatka; Wojciech Szeszkowski; Jacek Sieńko; Paweł Derlatka
Journal:  Pol J Radiol       Date:  2018-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.